ResearcherFujian Medical UniversityActive in the last 2 years
Minghuang Chen
Matched on ORCID iD 0009-0008-8732-7255; OpenAlex author ID A5068185796. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. Co-author DOI 10.1016/j.radonc.2025.111238↗
- Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study. Co-author DOI 10.21037/gs-20-202↗
- PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug. Co-author DOI 10.1097/mpa.0000000000000087↗
- Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathway. Last author DOI 10.1016/s1734-1140(13)71046-6↗
- Cucurmosin kills human pancreatic cancer SW-1990 cells in vitro and in vivo. Last author DOI 10.2174/18715206113139990109↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Congfei Wang · 4 shared papers, 2013–2020 · strength 0.24
- Paper Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolom… DOI 10.21037/gs-20-202↗
- Paper PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor r… DOI 10.1097/mpa.0000000000000087↗
- Paper Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathwa… DOI 10.1016/s1734-1140(13)71046-6↗
- Jieming Xie · 4 shared papers, 2013–2020 · strength 0.24
- Paper Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolom… DOI 10.21037/gs-20-202↗
- Paper PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor r… DOI 10.1097/mpa.0000000000000087↗
- Paper Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathwa… DOI 10.1016/s1734-1140(13)71046-6↗
- Hung-Yuan Yu · 1 shared paper, 2026 · strength 0.23
- Keng-Li Lan · 1 shared paper, 2026 · strength 0.23
- Nai‐Jung Chiang · 1 shared paper, 2026 · strength 0.23
- Yi‐Ming Shyr · 1 shared paper, 2026 · strength 0.23
- I‐Chun Lai · 1 shared paper, 2026 · strength 0.23
- Yu‐Wen Hu · 1 shared paper, 2026 · strength 0.23
- Yuan‐Hung Wu · 1 shared paper, 2026 · strength 0.23
- Chung‐Pin Li · 1 shared paper, 2026 · strength 0.23
- Tianhong Teng · 1 shared paper, 2020 · strength 0.11
- Heguang Huang · 1 shared paper, 2020 · strength 0.11
- Pengfei Guo · 1 shared paper, 2020 · strength 0.11
- Binbin Wei · 1 shared paper, 2020 · strength 0.11
- Jianghua Feng · 1 shared paper, 2020 · strength 0.11
- Heguang Huang · 2 shared papers, 2013–2014 · strength 0.09
- Paper PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor r… DOI 10.1097/mpa.0000000000000087↗
- Paper Cucurmosin induces the apoptosis of human pancreatic cancer CFPAC-1 cells by inactivating the PDGFR-β signalling pathwa… DOI 10.1016/s1734-1140(13)71046-6↗
- Heguang Huang · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.